Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
about
Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigensHumoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis.Serum autoantibody measurement for the detection of hepatocellular carcinomaPrognostic and diagnostic value of spontaneous tumor-related antibodiesHumoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus ErythematosusAutoantibodies against tumor-associated antigens for detection of hepatocellular carcinomaAutoimmune response to PARP and BRCA1/BRCA2 in cancerMini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinomaHigh-throughput screening for native autoantigen-autoantibody complexes using antibody microarrays.Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics.Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.Eukaryotic translation initiation factors and cancer.Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patientsDetection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.Efficacy of early treatment on 52 patients with preneoplastic hepatitis B virus-associated hepatocellular carcinoma by compound Phyllanthus Urinaria L.Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity.
P2860
Q33438890-324D194D-1DB9-4A71-8B3D-D8EE33F33FDEQ33594076-2806244A-E906-4832-93E8-158F7285D182Q33608271-E55CC7CE-E0FC-4B1D-9ADC-A55E64ADBFC3Q33739952-45CA42A9-54F4-464B-BB32-7DD07E0E5756Q33895858-5F3B37A9-CEB3-4950-9DF2-B0A39A3D0C25Q33895863-2A3BCF26-428E-407F-90F3-A983E8C976F0Q33895872-986E82A8-DA57-4371-A62A-F6117D70FFDBQ33946598-FC95B8A6-B357-4C48-AE2A-34104063D968Q34004797-51B160E5-0E29-4386-BD7F-E1C7CBD568DFQ34475795-10B5B9FA-230D-4BEE-81EB-A7E3169FA3AAQ35343013-40061AAD-6050-4ECD-9DF5-486F6F637412Q35673715-65D894CC-C771-4A8F-8A53-FA449BD737ABQ35715964-18E3A348-A811-4159-B681-E66174E8BBC1Q35793861-457107A3-87D4-4839-B7A8-B8C6FF03BB6BQ36611827-583383B9-E341-458D-BC5E-088A0FC325B4Q36640435-EB7D7693-FE0A-4396-BE10-B3844C08211EQ36923087-4ECADC77-A5FE-4836-A689-95F3BFB64829Q37213540-85F09F02-BD13-471D-B96E-E6C69E07213AQ37536632-7269B608-42C3-427D-9940-EE862D7ABA21Q37724875-62E20E2F-9ABA-4DA3-92C8-FDA4195BD447Q37801938-6BBD4604-9C5E-403C-A11F-5BAECD10820AQ38981242-BC736ADA-4FDD-4E30-B6DF-93FE6516B802Q39335058-FD93075A-F123-42D7-801F-ECCF6DD82782Q39400409-866C60C9-0528-4D76-BC89-8A286B1E63B1Q39592084-9E9922A0-FEC7-46FE-B9A0-23EC450DE3F6Q40522259-99D1F6DE-4063-4652-B3A0-5ED31F5917A1Q41882623-E3782E60-45BE-4913-8E40-4F268B346512Q43497337-A29AEB0F-E846-43C8-9D35-AE00507C35B0Q45351992-CE073283-932B-4EBB-86DC-C14CA449803EQ47187009-43F73EEB-3F91-4191-B842-E72B1D56E85D
P2860
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@ast
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@en
type
label
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@ast
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@en
prefLabel
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@ast
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Autoantibodies to tumor-associ ...... s of hepatocellular carcinoma.
@en
P2093
Jian-Ying Zhang
Junfeng Li
Kaijuan Wang
Suimin Qiu
Xuan-Xian Peng
Yusen Zhou
P2860
P356
10.1016/J.CANLET.2009.07.016
P407
P577
2009-08-15T00:00:00Z